ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $352,000 | +24.8% | 4,248 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $282,000 | -58.8% | 4,248 | -52.4% | 0.00% | -62.5% |
| Q4 2020 | $685,000 | +27.3% | 8,923 | -28.5% | 0.01% | +14.3% |
| Q3 2020 | $538,000 | -81.4% | 12,475 | -81.3% | 0.01% | -82.5% |
| Q2 2020 | $2,887,000 | +32.1% | 66,825 | -12.0% | 0.04% | +14.3% |
| Q1 2020 | $2,185,000 | -59.1% | 75,925 | -10.3% | 0.04% | -34.0% |
| Q4 2019 | $5,345,000 | +114.3% | 84,675 | -4.3% | 0.05% | +96.3% |
| Q3 2019 | $2,494,000 | +6.3% | 88,500 | 0.0% | 0.03% | +8.0% |
| Q2 2019 | $2,346,000 | +58.9% | 88,500 | +10.1% | 0.02% | +56.2% |
| Q1 2019 | $1,476,000 | +1254.1% | 80,400 | +900.0% | 0.02% | +1500.0% |
| Q2 2018 | $109,000 | – | 8,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |